What's Going On With Conduit Pharmaceuticals Shares Today?

Conduit Pharmaceuticals Inc. (NASDAQ:CDT) shares are trading higher Thursday after the company announced that the Japan Patent Office granted a composition of matter patent for its lead asset, AZD1656. Here’s what you need to know.

What To Know: AZD1656 is a glucokinase activator designed to target a range of autoimmune disorders. The patent approval in Japan comes after a similar patent was granted in Australia, marking continued progress in securing intellectual property protections for the company’s assets.

“This approval represents another significant milestone in ...

Full story available on Benzinga.com